Metcela - About the company
Metcela is a series C company based in Kanagawa (Japan), founded in 2016 by Kenichi Nogami. It operates as a Developer of cell-based therapeutic products for treating rare diseases. Metcela has raised $36.7M in funding from investors like UTEC, Cyberdyne and Japan Lifeline. The company has 101 active competitors, including 57 funded and 13 that have exited. Its top competitors include companies like CVRx, Impulse Dynamics and CorWave.
Company Details
Developer of cell-based therapeutic products for treating rare diseases. Research and development activities focus on creating biological treatments derived from cellular components. These medical products target conditions affecting pediatric patients and individuals diagnosed with rare health disorders. Clinical trials are conducted to evaluate the safety and efficacy of these therapeutic interventions.
- Website
- www.metcela.com/
- Email ID
- *****@metcela.com
Key Metrics
Founded Year
2016
Location
Kanagawa, Japan
Stage
Series C
Total Funding
$36.7M in 5 rounds
Latest Funding Round
Ranked
13th among 101 active competitors
Employee Count
5 as on Sep 30, 2026
Sign up to download Metcela's company profile
Metcela's funding and investors
Metcela has raised a total funding of $36.7M over 5 rounds. Its first funding round was on Sep 19, 2017. Its latest funding round was a Series C round on Jun 29, 2022 for $*****. 4 investors participated in its latest round. Metcela has 13 institutional investors.
Here is the list of recent funding rounds of Metcela:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 29, 2022 | 4594781 | Series C | 1549502 | 9583392 | 6882506 | 2404540 |
Jan 04, 2021 | 1943250 | Series B | 4304522 | 5759894 | 5612723 | |
May 20, 2020 | 7146496 | Series B | 7496663 | 5248542 |
Access funding benchmarks and valuations. Sign up today!View details of Metcela's funding rounds and investors
Metcela's founders and board of directors
Founder? Claim ProfileThe founders of Metcela is Kenichi Nogami. Kenichi Nogami and Iwamiya Takahiro are the CEOs of Metcela.
Here are the details of Metcela's key team members:
- Kenichi Nogami: Co-Founder & Co-CEO of Metcela. Contact Info: 1 email address
View details of Metcela's Founder profiles and Board Members
Metcela's employee count trend
Metcela has 5 employees as of Sep 26. Here is Metcela's employee count trend over the years:
Uncover Metcela's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Metcela's Competitors and alternates
Top competitors of Metcela include CVRx, Impulse Dynamics and CorWave. Here is the list of Top 10 competitors of Metcela, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | CVRx 2001, Minneapolis (United States), Public | Developer of implantable technology for hypertension and heart failure | $394M | 68/100 | |
2nd | Impulse Dynamics 1998, Marlton (United States), Series F | Provider of implantable device for treatment of chronic heart failure | $685M | 64/100 | |
3rd | Developer of implantable blood pumps for the treatment of heart failure | $127M | 61/100 | ||
4th |  Element Science 2013, San Francisco (United States), Series C | Wearable therapeutic device for treating sudden cardiac arrest | $193M | 61/100 | |
5th | SynCardia 2001, Tucson (United States), Public | Artificial heart | $72M | 60/100 | |
6th | Restore Medical 2016, Tel Aviv (Israel), Series B | Catheter-delivered implant for treatment of congestive heart failure | $32M | 57/100 | |
7th | Developer of an implantable cardiovascular device for treating heart failures | $51.9M | 57/100 | ||
8th | Procyrion 2005, Houston (United States), Series E | Developing percutaneous mechanical circulatory support for heart failure and cardiorenal syndrome | $114M | 56/100 | |
9th |  Berlin Heals 2010, Zug (Switzerland), Series B | Developer of a microcurrent device for heart failure treatment. This device is a novel cardiac implant that provides a minimal electrical direct current to the heart, promoting reverse remodeling of cardiac muscle tissue. The treatment has shown rapid improvements in heart function, size, and quality of life in clinical studies. The device is easily implantable and requires no additional medication or follow-up procedures. The company is currently conducting clinical studies to obtain regulatory approvals. | $34.6M | 51/100 | |
10th | Provider of implantable shunt to treat heart failure | $132M | 48/100 | ||
13th | Developer of cell-based therapeutic products for treating rare diseases | $36.7M | 45/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Metcela's competitors? Click here to see the top ones
Metcela's Investments and acquisitions
Metcela has made no investments or acquisitions yet.
Reports related to Metcela
Here is the latest report on Metcela's sector:
News related to Metcela
•
Metcela Inc. Completes the Series C Financing of Total $14 MillionPRWeb•Jun 28, 2022•Metcela, Cyberdyne, Japan Lifeline, Sony Innovation Fund and 2 others
•
Metcela Secures $12.7 Million Series B Financing to Initiate Phase I Clinical Trial in Chronic Heart Failure for MTC001 Cell TherapyPRWeb•Jan 04, 2021•Metcela, UTEC, Alfresa Holdings Corporation, Dai-Ichi Life and 2 others
•
Metcela Raises $12.7M in Series B FinancingFinSMEs•Jan 04, 2021•Metcela, Dai-Ichi Life, UTEC, KSP and 2 others
•
Metcela Raised $4 Million in Series B Funding to Launch a Phase I Clinical Trial for Heart Failure TherapyPRWeb•May 20, 2020•Metcela, Japan Lifeline, Sony Innovation Fund, University of Tsukuba and 1 other
•
•
With this financing, Metcela has now raised a total of 920 Million yen including the previous investments and grantsMetcela•Sep 17, 2018•Metcela, Beyond Next Ventures, Eight Roads Ventures, Japan Lifeline and 3 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Metcela
Explore our recently published companies
- Mckinnon - Canada based, 2014 founded, Unfunded company
- Web of Picasso - San Francisco based, Unfunded company
- Atlanta AI Enablement - Atlanta based, Unfunded company
- APPSInvent - North York based, 2016 founded, Unfunded company
- GfM Gesellschaft fur Micronisierung - Bremen based, 1985 founded, Unfunded company
- PERCH - Noida based, 2023 founded, Unfunded company
